Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors ...

Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

This biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. The company recently launched a new product that could be the start of a ...

This company is a leader in two major areas, and these businesses are generating billion-dollar revenue. The stock looks very ...

OpenAI has finalized a deal to sell employees’ shares to investors that values the artificial intelligence company at $500 ...

I am among the many potential audience members for “Art,” the new revival of Yazmina Reza’s sly, knowing play, who has never ...

New data suggest antithymocyte globulin, verapamil, and baricitinib might help preserve beta cell function in new-onset type ...

Cystic fibrosis patients rarely used to see age 30. Now, with this Iowa doctor's work, people are living well into their 80s — and even running.

That's when Klein decided to give his corporate clients an ultimatum: Migrate your data to our cloud products, or we will no ...

Where to eat, sleep, and live out your cowboy dreams in this Wyoming town, where affluence meets authentic Western charm.